Davide Leone & Partners Investment Company’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Davide Leone & Partners Investment Company’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-363,779	Closed	-$62.9M	–	20
2015 Q1	$62.9M	Buy	+363,779	New	+$53.4M	5.14%	12

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Davide Leone & Partners Investment Company's SLXP Position: Q2 2015 in Review

Davide Leone & Partners Investment Company sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 363,779 shares — an estimated $62.9M sold.

Davide Leone & Partners Investment Company first reported a position in SLXP in Q1 2015 and held it in 1 quarter. The position peaked at $62.9M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Davide Leone & Partners Investment Company reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Davide Leone & Partners Investment Company sold 363,779 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $62.9M.
Davide Leone & Partners Investment Company first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q1 2015 and held it in 1 quarter.
Davide Leone & Partners Investment Company's SALIX PHARMACEUTICALS LTD DEL position peaked at $62.9M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Davide Leone & Partners Investment Company's 13F filing for Q2 2015, filed 14 Aug 2015.